Compare Iris Energy Limited (IREN) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iris Energy Limited vs Revvity Inc — how do they compare? Iris Energy Limited trades at $38.79 (market cap $12.02B), while Revvity Inc trades at $107.3 (market cap $12.29B). The key difference: Iris Energy Limited and Revvity Inc are close in size by market cap, and Revvity Inc pays a 0.25% dividend while Iris Energy Limited pays none. Which is the better fit depends on your goals.
| IREN | RVTY | |
|---|---|---|
Market Cap | $12.02B | $12.29B |
Sector | Energy | Technology |
52-Week High | $76.41 | $117.75 |
52-Week Low | $15.40 | $82.26 |
Enterprise Value | $13.77B | $14.78B |
Dividend Yield | — | 0.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IREN is trading at $39.44, up 17.31% today amid volatile AI infrastructure sector sentiment. The stock faces bearish technical signals with negative ROE/ROA but maintains strong analyst support (71% buy ratings) and a $79.11 consensus price target. Recent earnings misses contrast with projected 2026 revenue growth to $757M and net profit of $158M, while news highlights both AI opportunity execution risks and potential Anthropic partnership upside.
Outlook balances high growth potential against execution risks. The transformation from Bitcoin mining to AI infrastructure offers substantial upside if contracted revenue targets materialize, but recent price weakness reflects investor concerns about competitive threats and spending sustainability. Near-term catalysts include Q2 2026 earnings and any confirmation of the speculated Anthropic deal.
Revvity (RVTY) trades at $108.38, down 1.61% over the past day, with a bullish technical signal from moving averages. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $1.06 exceeding expectations. Recent news highlights expansion in AI capabilities through Anthropic Claude integration and FDA clearance for a testosterone assay, signaling innovation in its life sciences and diagnostics segments.
The outlook remains positive with a consensus price target of $111.43, suggesting modest upside. Strong profitability margins and recent strategic developments support growth, though risks include margin pressures and macroeconomic headwinds affecting near-term performance. Analyst sentiment is divided but leans bullish with no sell ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iris Energy Limited
Iris Energy is a next-generation data center company that powers Bitcoin mining and AI workloads using 100% renewable energy. It focuses on building sustainable infrastructure for the global digital economy.
Read more on IREN →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
